About HBGHX
Hartford Healthcare HLS Fund Class IB is an actively managed mutual fund specializing in the health care sector. Its primary function is to achieve long-term capital appreciation by investing at least 80% of its assets in the equity securities of companies involved in health care, including pharmaceuticals, medical device makers, service providers, biotechnology firms, hospitals, and managed care organizations. The fund is managed by Hartford Funds Management Company, with Wellington Management serving as the sub-adviser, providing deep sector expertise and research support.
This institutional share class is designed for investors seeking dedicated exposure to the health care industry, a sector known for ongoing innovation and significant impact on global economic and public health trends. Notable holdings typically include leading companies such as Eli Lilly and Co, UnitedHealth Group, and Merck & Co, with the top ten holdings representing a substantial portion of the portfolio assets. The fund is classified in Morningstar’s Health sector category and employs a large growth investment style, maintaining a diversified approach across multiple health care subsectors.
Fund Family Hartford Mutual Funds
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange Nasdaq
Ticker Symbol HBGHX
Share Class Ib
Index S&P Composite 1500 Health Care TR
HBGHX had a total return of 23.83% in the past year, including dividends. Since the fund's
inception, the average annual return has been 20.50%.
